or Try an Advanced Search...

    Embolectomy Stocks List

    Symbol Grade Name % Change
    NARI A Inari Medical, Inc. 0.70
    LMAT B LeMaitre Vascular, Inc. 7.34
    EW D Edwards Lifesciences Corporation 0.79
    View As Page of Charts
    Related Industries: Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Catheter Medicine Artery Blood Clots Incision Perfusion Veins Angiology Bypass Cannula Cardiac Monitoring Cardiac Output Cardiac Surgery Cardiovascular System Care Products Clinical Medicine Closure Systems Deep Vein Thrombosis Dialysis Disease

    Related ETFs - A few ETFs which own one or more of the above listed Embolectomy stocks.

    Symbol Grade Name Weight
    XHE B SPDR S&P Health Care Equipment 5.13
    IHI A iShares U.S. Medical Devices ETF 5.08
    BEEZ C Honeytree U.S. Equity ETF 4.04
    TMFS A Motley Fool Small-Cap Growth ETF 3.31
    FFLS A The Future Fund Long/Short ETF 2.83
    View all Embolectomy ETFs...
    Compare ETFs
    Compare BEEZ to TMFS Compare IHI to FFLS Compare XHE to BEEZ

        Embolectomy Stocks Recent News

        Date Stock Title
        Nov 1 LMAT LeMaitre to Participate at Upcoming Investor Conferences in November
        Nov 1 LMAT LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Nov 1 EW Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance
        Oct 31 LMAT LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
        Oct 31 LMAT LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates
        Oct 31 LMAT LeMaitre: Q3 Earnings Snapshot
        Oct 31 LMAT LeMaitre Vascular GAAP EPS of $0.49 beats by $0.06, revenue of $54.82M beats by $1.31M
        Oct 31 LMAT LeMaitre Q3 2024 Financial Results
        Oct 31 NARI Edwards, Medtronic and Inari share trial data at TCT conference
        Oct 31 EW Edwards, Medtronic and Inari share trial data at TCT conference
        Oct 30 LMAT LeMaitre Vascular Q3 2024 Earnings Preview
        Oct 30 EW Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
        Oct 30 EW Edwards Life says pivotal study for Evoque hit one-year goal
        Oct 30 EW TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
        Oct 30 NARI Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 29 NARI Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...
        Oct 29 EW JPMorgan views Edwards Lifesciences TAVR data positively
        Oct 29 NARI PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
        Oct 29 NARI Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y
        Oct 29 NARI Key Takeaways From Inari Medical Analyst Ratings
        Related Industries: Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Catheter Medicine Artery Blood Clots Incision Perfusion Veins Angiology Bypass Cannula Cardiac Monitoring Cardiac Output Cardiac Surgery Cardiovascular System Care Products Clinical Medicine Closure Systems Deep Vein Thrombosis Dialysis Disease
        Embolectomy

        Embolectomy is the emergency surgical removal of emboli which are blocking blood circulation. It usually involves removal of thrombi (blood clots), and is then referred to as thrombectomy. Embolectomy is an emergency procedure often as the last resort because permanent occlusion of a significant blood flow to an organ leads to necrosis. Other involved therapeutic options are anticoagulation and thrombolysis.

        More about Embolectomy
        Browse All Tags